SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/0E30B7615F557E4F143C02CE333281C65261C967EBB8D8AB505134D38D1B35FA31D629D61CA76392F2F96769C7669598>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/0E30B7615F557E4F143C02CE333281C65261C967EBB8D8AB505134D38D1B35FA31D629D61CA76392F2F96769C7669598
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/0E30B7615F557E4F143C02CE333281C65261C967EBB8D8AB505134D38D1B35FA31D629D61CA76392F2F96769C7669598
http://www.w3.org/2000/01/rdf-schema#comment
"The RNF183-IL-8 axis is responsible for the resistance of colorectal cancer (CRC)cells to the MEK1/2 inhibitor trametinib and may serve as a candidate target for combined therapy for CRC."
xsd:string
http://purl.uniprot.org/uniprot/#_8A2C5406D4A0BB12C0A14A85CC030677B49085A50AC066CF934A9246CA6A2969BB3B45B01CAD4BD58BFEA30DCA3F838E
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/0E30B7615F557E4F143C02CE333281C65261C967EBB8D8AB505134D38D1B35FA31D629D61CA76392F2F96769C7669598
http://purl.uniprot.org/uniprot/Q96D59
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/0E30B7615F557E4F143C02CE333281C65261C967EBB8D8AB505134D38D1B35FA31D629D61CA76392F2F96769C7669598
http://purl.uniprot.org/uniprot/#_Q96D59-mappedCitation-28756770
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/0E30B7615F557E4F143C02CE333281C65261C967EBB8D8AB505134D38D1B35FA31D629D61CA76392F2F96769C7669598